scholarly journals Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease

2013 ◽  
Vol 110 (28) ◽  
pp. 11606-11611 ◽  
Author(s):  
M. Lehmann ◽  
C. M. Madison ◽  
P. M. Ghosh ◽  
W. W. Seeley ◽  
E. Mormino ◽  
...  
2019 ◽  
Vol 23 ◽  
pp. 101848 ◽  
Author(s):  
Rik Ossenkoppele ◽  
Leonardo Iaccarino ◽  
Daniel R. Schonhaut ◽  
Jesse A. Brown ◽  
Renaud La Joie ◽  
...  

2016 ◽  
Vol 12 ◽  
pp. P305-P306
Author(s):  
Rik Ossenkoppele ◽  
Daniel R. Schonhaut ◽  
Jesse Brown ◽  
James P. O'Neil ◽  
Mustafa Janabi ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-12 ◽  
Author(s):  
Ya-Ting Chang ◽  
Chi-Wei Huang ◽  
Wen-Neng Chang ◽  
Jun-Jun Lee ◽  
Chiung-Chih Chang

Background. We aimed to investigate how altered intrinsic connectivity networks (ICNs) affect pathologic changes of Alzheimer’s disease (AD) at a network-based level. Methods. Thirty normal controls (NCs), 23 patients with AD-mild cognitive impairment (MCI), and 20 patients with AD-dementia were enrolled. We compared the organization of grey matter structural covariance and functional connectivity in ICNs between NCs and all AD patients who were amyloid β (Aβ)-positive. We further used seed-based interregional covariance analysis to compare structural and Aβ plaque covariance in default mode network (DMN) between AD-MCI and AD-dementia groups. Results. The patients with AD had increased functional interregional covariance among the regions of the ICN anchored to dorsal caudate (DC) seeds compared to the NCs. The increased connectivity was associated with extended patterns of reduced Aβ plaque covariance in the AD-dementia group compared to the AD-MCI group within the striatal network anchored to DC seeds. Patterns of lower Aβ plaque covariance in the AD-dementia group compared to the AD-MCI group were more extended within the network anchored to DC seeds than within the DMN, which was undergoing functional failure in the patients with AD. Significant decreased structural covariance in the AD-dementia group compared to the AD-MCI group was more extended in the DMN during functional failure. Conclusions. Functional connectivity in ICNs affects the topographic spread of molecular pathologies. The temporal trajectory of pathologic alterations can be well demonstrated by pathologic covariance comparisons between different clinical stages. Pathologic covariance can provide critical support to pathologic interactions at network and molecular levels.


2020 ◽  
pp. 1-7
Author(s):  
Raymond R. Romano ◽  
Michael A. Carter ◽  
Mary S. Dietrich ◽  
Ronald L. Cowan ◽  
Stephen P. Bruehl ◽  
...  

Background: This study evaluated whether the apolipoprotein ɛ4 (APOE4) allele, a genetic marker associated with increased risk of developing late-onset Alzheimer’s disease (AD), was associated with differences in evoked pain responsiveness in cognitively healthy subjects. Objective: The aim was to determine whether individuals at increased risk of late-onset AD based on APOE allele genotype differ phenotypically in their response to experimentally-induced painful stimuli compared to those who do not have at least one copy of the ɛ4 allele. Methods: Forty-nine cognitively healthy subjects aged 30–89 years old with the APOE4 allele (n = 12) and without (n = 37) were assessed for group differences in pain thresholds and affective (unpleasantness) responses to experimentally-induced thermal pain stimuli. Results: Statistically significant main effects of APOE4 status were observed for both the temperature at which three different pain intensity percepts were reached (p = 0.040) and the level of unpleasantness associated with each (p = 0.014). APOE4 positive participants displayed lower overall pain sensitivity than those who were APOE4 negative and also greater overall levels of pain unpleasantness regardless of intensity level. Conclusion: Cognitively healthy APOE4 carriers at increased risk of late-onset AD demonstrated reduced thermal pain sensitivity but greater unpleasantness to thermal pain stimuli relative to individuals at lower risk of late-onset AD. These results suggest that altered evoked pain perception could potentially be used as a phenotypic biomarker of late-onset AD risk prior to disease onset. Additional studies of this issue may be warranted.


2020 ◽  
Vol 16 (S1) ◽  
Author(s):  
Joseph Therriault ◽  
Tharick A. Pascoal ◽  
Melissa Savard ◽  
Sulantha Mathotaarachchi ◽  
Andréa Lessa Benedet ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document